Specifics of the use of NSAIDs in senior age

Close metadata

Recommended articles:

Sarcopenia as a non-motor symptom of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):15-22

Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — recommendations and real-life clinical setting. Russian Journal of Preventive Medicine. 2024;(6):68-73

Physical methods of correction of arterial hypertension: modern concepts. (A literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):41-47

Efficacy of different postural control training in elderly people with chronic cerebral ischemia. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):42-48

Features of autonomic regulation of heart rate variability in young people at the cardiovascular pathology prevention. Russian Journal of Preventive Medicine. 2024;(8):76-81

The possibilities of Mexidol in the complex therapy of arterial hypertension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580

Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Russian Journal of Preventive Medicine. 2024;(11):85-93

Efficacy and safety of metamizole sodium for pain syndrome in adults and children: a systematic review. Russian Journal of Pain. 2024;(4):65-80

Predictors of Engagement and Active participation of Patients with Uncontrolled Hypertension in the Telehealth Surveillance Program. Russian Journal of Preventive Medicine. 2024;(12):37-43

The role of quantitative body composition analysis in population in the assessment and monitoring of cardiovascular risk metabolic factors. Russian Journal of Preventive Medicine. 2024;(12):128-134

Nonsteroidal anti-inflammatory drugs (NSAIDs) have a strong analgesic and anti-inflammatory effects and are widely used in clinical practice. Patients with chronic disorders of the joints, in particular the spine, are main consumers of NSAIDs. However, risk factors for side-effects should be taken into consideration in the treatment with NSAIDs, especially in patients of old age. The careful control of treatment taking into account the risk of developing gastrointestinal and cardiovascular events is needed.

Keywords:

NSAIDs

NSAID-gastropathies

cardiovascular risks

hypertension

elderly age

nimesulide

Authors:

Pakhomova I.G.

Mechnikov Northwestern State Medical University, St. Petersburg

Khoroshinina L.P.

Northwestern Federal Medical Research Center Almazov, St. Petersburg, Russia

List of references:

Zvartau JeJe. Racional'noe obezbolivanie. Racional'noe obezbolivanie v obshhej praktike. Prakticheskoe rukovodstvo dlja vrachej. Pod red. akad. RAEN chlena-korr. RAMN zasluzhennogo dejatelja nauki RF prof. Vejna AM. M. 1999. (In Russ.).
Zhu K, Devine A, Dick I, Prince RL. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women. Spine. 2007;32(18):2012-2018. doi:10.1097/brs.0b013e318133fb82
Anohin PK, Orlov IV, Erohina LG. Bol'. BMJe. 1976;3:869-881. (In Russ.).
Kurushina OV, Barulin AE, Dumcev VV. Sovremennye podhody k terapii hronicheskoj tazovoj boli. Russkij medicinskij zhurnal. 2016;13:847-851. (In Russ.).
Pahomova IG. NO-associirovannyj NPVP: novye vozmozhnosti minimizacii oslozhnenij so storony zheludochno-kishechnogo trakta. Jeffektivnaja farmakoterapija. 2015;23:50-54. (In Russ.).
Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A, Simon L, Zlotnick S, Fort J. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Disease. 2004;63(8):931-939. doi: 10.1136/ard.2003.020313
DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. American Journal of Therapeutics. 2011;18(3):216-226. doi: 10.1097/MJT.0b013e3181cec307
Pahomova IG, Horoshinina LP. Vnov' o probleme bezopasnosti NPVP. Racional'nyj vybor preparata. Consilium Medicum. 2015;2(17):22-26. (In Russ.).
Karateev AE, Jahno NN, Lazebnik LB, Kukushkin ML, Drozdov VN, Isakov VA, Nasonov EL. Primenenie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendacii. Pod red. Karateeva AE. M.: IMA press; 2009. (In Russ.).
Chan F, Lanas A, Scheiman J et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010;376:173-179. doi: 10.1016/S0140-6736(10)60673-3
Solomon D, Sctmeeweiss S, Levin R, Avorn J. Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004;44:140-145. doi: 10.1161/01.HYP.0000136134.31846.83
Fierro-Carrion G, Ram CV. Non-steridal antiinflammatory drugs NSAIDs and blood pressure. American Journal of Cardiology. 1997;80:775-776.
Lopez-Ovejero JA, Weber MA, Drayer JI, Sealey JE, Laragh JH. Effects of Indomethacin Alone and during Diuretic or β-Adrenoreceptor-Blockade Therapy on Blood Pressure and the Renin System in Essential Hypertension. Clinical Science. 1978;55(4):203-205. doi: 10.1042/cs055203s
Fournier J, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc J-L. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. European Journal of Clinical Pharmacology. 2012;68:1533-1540. doi: 10.1007/s00228-012-1283-9
Pawlovsky N. Cardiovascular risk: Are all NSAIDs alike? Canadian Pharmacists Journal (Ott). 2013;146(2):80-83. doi: 10.1177/1715163513481569
Combe B, Swergold G, McLay J, McCarthy T, Zerbini C, Emery P, Connors L, Kaur A, Curtis S, Laine L, Cannon CP. Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). Rheumatology. 2009;48(4):425-432. doi: 10.1093/rheumatology/kep005
Fredman B, Zohar E, Tarabykin A, Shapiro A, Jedeikin R. Continuous intravenous diclofenac does not induce opioid-sparing or improve analgesia in geriatric patients undergoing major orthopedic surgery. Journal of Clinical Anesthesia. 2000;12(7):531-536. doi: 10.1016/S0952-8180(00)00212-9
Morgan T, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. American Journal of Hypertension. 2000;13(11):1161-1167. doi: 10.1016/s0895-7061(00)01204-8
Laporte J, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety. 2004;27:411-420. doi: 10.2165/00002018-200427060-00005
Castellsague J, Pisa F, Rosolen V, Drigo D, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiology and Drug Safety. 2013;22(4):365-375. doi: 10.1002/pds.3385
Kriegel W, Korff K, Ehrlich J et al. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. International Journal of Clinical Practice. 2001;55(8):510-514. doi: 10.2165/00044011-199510030-00002
Karateev AE, Alekseeva LI, Bratygina EA, Ashirova TB. Ocenka chastoty razvitija pobochnyh jeffektov pri dlitel'nom primenenii nimesulida v real'noj klinicheskoj praktike. Russkij medicinskij zhurnal. 2009;17(21):1466-1472. (In Russ.).

Close metadata